IRICoR is a not-for-profit drug discovery and commercialization centre based at the Institute for Research in Immunology and Cancer (IRIC) on the Université de Montréal campus. Our main objective is to rapidly translate highly innovative scientific projects into high value novel therapies in oncology, immunology, and related indications through strong partnerships with the private sector — thereby efficiently bridging the innovation translation gap between early stage academic research and industry.
| Website | http://www.iricor.ca |
| Employees | 8 (7 on RocketReach) |
| Founded | 2008 |
| Address | 2950 Chemin de Polytechnique, Montreal, Quebec H3C 3J7, CA |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Drug Discovery, Drug Development, Immunology Research, Cancer Research, Pharmaceutical Research, Biotechnology, Life Sciences, Drug Commercialization, Scientific Research, Research Institute, Innovation, Therapeutics, Clinical Research, Oncology, Immunotherapy, Translational Research, Biomedical Research, Pharmaceutical Development, Health Research, Academic Research |
| Competitors | Pfizer, AstraZeneca, Bristol Myers Squibb, Genentech, Boehringer Ingelheim, Zymeworks Inc., AbCellera, Medicen Paris Region, Viela Bio, Boreal Genomics +42 more (view full list) |
Looking for a particular IRICoR employee's phone or email?
Claude Larose is the VP Business Development of IRICoR.
7 people are employed at IRICoR.
IRICoR is based in Montreal, Quebec.